Enrique Nogueira*, Betariz del Olmo, Concepcion Lobo, Cecilia Gonzalez, Patricia Llovet and Cristina Martinez
Volume4-Issue12
Dates: Received: 2023-12-12 | Accepted: 2023-12-13 | Published: 2023-12-14
Pages: 1664-1666
Abstract
We here report on a case of a 46-year-old male under evaluation for persistent long-term (for more than 20 years) Hypertriglyceridemia (HTG) submitted to us for a genomic study based in an exome analysis of a mixed dyslipidemia, with Hypercholesterolemia (HC) and HTG (in multiple serum determinations, in recent years on Abbott Alinity Chemistry Analyzers), with unequal response to treatment (with statins for HC, and fibrates for HTG), with a progressive decrease in cholesterol values (now at almost optimal values of LDL cholesterol, around 125 mg/dL) while with no effect on TGs measurements (commonly around 600 mg/dL).
FullText HTML
FullText PDF
DOI: 10.37871/jbres1848
Certificate of Publication
Copyright
© 2023 Nogueira E, et al. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Nogueira E, del Olmo B, Lobo C, Gonzalez C, Llovet P, Martinez C. Long-term Pseudo-Hypertriglyceridemia due to Novel GK Splice Variant c.894+2T>C. J Biomed Res Environ Sci. 2023 Dec 14; 4(12): 1664-1666. doi: 10.37871/jbres1848, Article ID: JBRES1848, Available at: https://www.jelsciences.com/articles/jbres1848.pdf
Subject area(s)
References
- Ison HE, Clarke SL, Knowles JW. Familial Hypercholesterolemia. 2014 Jan 2 [updated 2022 Jul 7]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 24404629.
- De Castro-Orós I, Pocoví M, Civeira F. The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations. Appl Clin Genet. 2010 Aug 5;3:53-64. doi: 10.2147/tacg.s8285. PMID: 23776352; PMCID: PMC3681164.
- Sharifi M, Futema M, Nair D, Humphries SE. Genetic Architecture of Familial Hypercholesterolaemia. Curr Cardiol Rep. 2017 May;19(5):44. doi: 10.1007/s11886-017-0848-8. PMID: 28405938; PMCID: PMC5389990.
- Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Borén J, Bruckert E, Catapano AL, Descamps OS, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Raal FJ, Ray KK, Santos RD, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A, Watts GF, Wiklund O; European Atherosclerosis Society Consensus Panel. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014 Aug;2(8):655-66. doi: 10.1016/S2213-8587(13)70191-8. Epub 2013 Dec 23. PMID: 24731657; PMCID: PMC4201123.
- Fernández-Pardo J, Quílez-Fernández JL, Pedro-Botet J. Screening for hyperglycerolemia by triglyceride assay in urine. J Clin Lipidol. 2019 Sep-Oct;13(5):854-855. doi: 10.1016/j.jacl.2019.09.006. Epub 2019 Sep 14. PMID: 31604684.
- Arrobas-Velilla T, Mondéjar-García R, Gómez-Gerique JA, Cañizares Díaz I, Cruz Mengibar MC, Orive de Diego A, Fabiani-Romero F. Pseudo-hypertriglyceridaemia or hyperglycerolemia? Clin Investig Arterioscler. 2013 Jul-Aug;25(3):123-6. doi: 10.1016/j.arteri.2013.05.005. Epub 2013 Jul 19. PMID: 23877006.
- Pant V, Pyakurel D, Gautam K, Pradhan S. Pseudo-hypertriglyceridaemia in glycerol kinase deficiency misdiagnosed and treated as true hypertriglyceridaemia. BMJ Case Rep. 2022 Mar 15;15(3):e248251. doi: 10.1136/bcr-2021-248251. PMID: 35292548; PMCID: PMC8928288.
- Arrieta F, Ojeda S, Rueda Á, Stanescu S, Belanger-Quintana A, Martínez-Pardo M. Déficit de glicerol kinasa en el adulto: hipertrigliceridemia resistente a tratamiento dietético y farmacológico [Glycerol kinase deficiency in adult patient: hypertriglyceridemia resistance to diet and pharmacological treatment]. Nutr Hosp. 2018 Aug 2;35(4):993-995. Spanish. doi: 10.20960/nh.1921. PMID: 30070892.
